Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
4.66
-0.88 (-15.88%)
At close: Aug 15, 2025, 12:20 PM

Profound Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-27.82M -28.57M -28.67M -30.7M
Depreciation & Amortization
891.06K 929K 1.54M 1.86M
Stock-Based Compensation
2.58M 3.42M 4.24M 7.21M
Other Working Capital
-1.03M 78K -1.27M -26K
Other Non-Cash Items
299.94K 828K 2.66M 132K
Deferred Income Tax
n/a 232K n/a -293K
Change in Working Capital
591K 540K -5.63M -877K
Operating Cash Flow
-23.45M -22.3M -25.8M -22.36M
Capital Expenditures
n/a 1.96 n/a -593K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -561K
Investing Cash Flow
n/a n/a n/a -593K
Debt Repayment
-2.56M -1.2M 6.92M -386K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-4.85M 2.67M -299.64K -480.73K
Financial Cash Flow
54.7M 1.76M 7.03M 5.95M
Net Cash Flow
28.7M -20.3M -20.64M -16.76M
Free Cash Flow
-23.45M -22.61M -25.8M -22.95M